USD 1.8
(0.0%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 141.2 Million | 56.5 Million | 26.4 Million | -83.5 Million | 112.9 Million | 146.1 Million |
Net Income | -365.4 Million | -42.6 Million | -99.3 Million | -660 Million | -29 Million | 69.6 Million |
Depreciation & Amortization | 51.1 Million | 58.2 Million | 68.5 Million | 124.2 Million | 91.9 Million | 86.5 Million |
Deferred income taxes | - | - | - | - | 52.9 Million | -27.9 Million |
Stock-based compensation | - | - | - | - | 900 Thousand | 1.4 Million |
Change in working capital | -2.8 Million | -1.1 Million | 900 Thousand | 1.4 Million | -3.1 Million | 17.5 Million |
Other non-cash items | 458.3 Million | 42 Million | 56.3 Million | 450.9 Million | -700 Thousand | -1 Million |
Investing Cash Flow | 30.9 Million | 86.7 Million | -32.5 Million | -108.5 Million | -80.4 Million | -69 Million |
Investments in PPE | -20.1 Million | -19.1 Million | -21.4 Million | -44.2 Million | -50 Million | -68.6 Million |
Acquisitions | 75.6 Million | 134.4 Million | 13 Million | -2 Million | -1.1 Million | - |
Investment purchases | -91.8 Million | -200 Thousand | -300 Thousand | -600 Thousand | -1.1 Million | -1.1 Million |
Sales/Maturities of investments | 67.2 Million | -165.9 Million | 3 Million | 400 Thousand | 3.6 Million | 1.2 Million |
Other Investing Activities | 44.6 Million | 137.5 Million | -26.8 Million | -62.1 Million | -31.8 Million | 700 Thousand |
Financing Cash Flow | -215 Million | -122.2 Million | 60.9 Million | 82.3 Million | -10.7 Million | -10.3 Million |
Debt repayment | -189.8 Million | -139.5 Million | -66.4 Million | -100 Thousand | -522.3 Million | -200 Thousand |
Dividends payments | -19 Million | - | - | - | -37.9 Million | -37.8 Million |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | 100 Thousand | 100 Thousand |
Other Financing Activities | -6.2 Million | 17.3 Million | 127.3 Million | 82.4 Million | 549.4 Million | 27.6 Million |
Accounts receivables | -17 Million | -21.2 Million | -13.9 Million | 29.1 Million | -700 Thousand | -2.1 Million |
Accounts payables | 16.3 Million | 18.5 Million | 12.6 Million | -29.3 Million | -4.9 Million | 18.4 Million |
Inventory | -900 Thousand | -200 Thousand | 400 Thousand | 500 Thousand | 400 Thousand | -300 Thousand |
Other working capital | -1.2 Million | 1.8 Million | 1.8 Million | 1.1 Million | 2.1 Million | 17.8 Million |
Cash at beginning of period | 226.2 Million | 212.8 Million | 164.6 Million | 270.7 Million | 246.8 Million | 183.9 Million |
Cash at end of period | 178.8 Million | 226.2 Million | 212.8 Million | 164.6 Million | 270.7 Million | 246.8 Million |
Capital Expenditure | -20.1 Million | -19.1 Million | -21.4 Million | -44.2 Million | -50 Million | -68.6 Million |
Effect of forex changes on cash | 7 Million | -7.6 Million | -6.6 Million | 3.6 Million | 2.1 Million | -3.9 Million |
Net cash flow / Change in cash | -47.4 Million | 13.4 Million | 48.2 Million | -106.1 Million | 23.9 Million | 62.9 Million |
Free Cash Flow | 121.1 Million | 37.4 Million | 5 Million | -127.7 Million | 62.9 Million | 77.5 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -26 Million | -26 Million | -365.4 Million | -296.2 Million | -148.1 Million | -69.2 Million |
Depreciation & Amortization | 10.85 Million | 10.85 Million | 51.1 Million | 23.8 Million | 9.15 Million | 27.3 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -5.65 Million | -5.65 Million | -2.8 Million | -1.8 Million | -9.05 Million | -1 Million |
Other non-cash items | 32.65 Million | 32.65 Million | 458.3 Million | 403.3 Million | 188.75 Million | 157.2 Million |
Investing Cash Flow | 71.05 Million | 71.05 Million | 30.9 Million | -49.4 Million | -24.7 Million | 80.3 Million |
Investments in PPE | -2 Million | -2 Million | -20.1 Million | -14 Million | -4.15 Million | -6.1 Million |
Acquisitions | 215.5 Million | - | 75.6 Million | -1 Million | - | 76.6 Million |
Investment purchases | -65.5 Million | - | -91.8 Million | -35.2 Million | - | -56.6 Million |
Sales/Maturities of investments | 100 Thousand | - | 67.2 Million | 800 Thousand | - | 66.4 Million |
Other Investing Activities | 73.05 Million | 73.05 Million | 44.6 Million | -20.55 Million | -20.55 Million | 42.85 Million |
Financing Cash Flow | -49.15 Million | -49.15 Million | -215 Million | -190.2 Million | -95.1 Million | -24.8 Million |
Debt repayment | -51.1 Million | - | -189.8 Million | -168.2 Million | - | -21.6 Million |
Dividends payments | -44.2 Million | -22.1 Million | -19 Million | -19 Million | -9.5 Million | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -27.05 Million | -27.05 Million | -6.2 Million | -85.6 Million | -85.6 Million | -12.4 Million |
Accounts receivables | - | - | -17 Million | -8.5 Million | -8.5 Million | - |
Accounts payables | - | - | 16.3 Million | 7.25 Million | - | - |
Inventory | - | - | -900 Thousand | -450 Thousand | -450 Thousand | - |
Other working capital | -5.65 Million | -5.65 Million | -1.2 Million | -100 Thousand | -100 Thousand | -500 Thousand |
Cash at beginning of period | 178.8 Million | - | 226.2 Million | 349.3 Million | 349.3 Million | 226.2 Million |
Cash at end of period | 253.9 Million | 31.8 Million | 178.8 Million | 178.8 Million | -79.5 Million | 349.3 Million |
Capital Expenditure | -2 Million | -2 Million | -20.1 Million | -14 Million | -4.15 Million | -6.1 Million |
Effect of forex changes on cash | -1.95 Million | -1.95 Million | 7 Million | -450 Thousand | -450 Thousand | 3.95 Million |
Net cash flow / Change in cash | 75.1 Million | 31.8 Million | -47.4 Million | -170.5 Million | -428.8 Million | 123.1 Million |
Free Cash Flow | 9.85 Million | 9.85 Million | 121.1 Million | 67.5 Million | 36.6 Million | 53.6 Million |
GTEH
SSM
6585
ANTGRAPHIC
0HR3
PARMCOS-B